Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Bima Sakti Pertiwi Tbk. (PAMG) Price & Performance

UBC Medical Indonesia Tbk.Trade
Bima Sakti Pertiwi Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Bima Sakti Pertiwi Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Bima Sakti Pertiwi Tbk. trades at Rp52 (market cap 162.5B, 2.57M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.5× Bima Sakti Pertiwi Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 2.57M). Which is the better fit depends on your goals.

LABSPAMG
Market Cap
576.7B162.5B
Volume
3.48M2.57M
Lot
34.82K25.72K
Turnover
522.79M130.93M
Average Price
150.1350.9
Value
522.79M130.93M
Indicative Equilibrium Price
14852
Indicative Equilibrium Volume
35023

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
PAMG
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Bima Sakti Pertiwi Tbk.

PT Bima Sakti Pertiwi Tbk (the Company) was established based on the Notarial Deed of Raden Minarno Hardjokoesoemo, S.H., Deputy Notary in Tanjungpinang, No. 30, dated April 28, 1980.

Read more on PAMG